Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
Clinical Transplants|August 7, 2014
The differential pathogenicity of HLA antibodies: what a large cross-sectional study can tell usNils Lachmann, Constanze Schönemann
Clinical Transplants|March 28, 2008
Summary of the effect of de novo HLA antibodies on chronic kidney graft failurePaul Terasaki, Nils Lachmann, Junchao Cai
Clinical Transplants|March 28, 2008
Donor-specific HLA antibodies in chronic renal allograft rejection: a prospective trial with a four-year follow-upNils Lachmann, Paul I Terasaki, Constanze Schönemann
Cytometry. Part B, Clinical Cytometry|October 12, 2004
Flow cytometric detection of complement-activating HLA antibodiesConstanze Schönemann, Nils Lachmann, Holger Kiesewetter, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|August 8, 2013
Luminex(®) and its applications for solid organ transplantation, hematopoietic stem cell transplantation, and transfusionNils Lachmann, Kremena Todorova, Harald Schulze, et al.
Transplantation|January 29, 2013
Systematic comparison of four cell- and Luminex-based methods for assessment of complement-activating HLA antibodiesNils Lachmann, Kremena Todorova, Harald Schulze, et al.
Plos Computational Biology|July 27, 2021
Computational Eurotransplant kidney allocation simulations demonstrate the feasibility and benefit of T-cell epitope matchingMatthias Niemann, Nils Lachmann, Kirsten Geneugelijk, et al.
Frontiers in Genetics|October 31, 2024
epiArt: a graphical HLA eplet amino acid repertoire translation reveals the need for an epitope driven revision of allele group nomenclatureIlias Doxiadis, Claudia Lehmann, Nils Lachmann, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 13, 2024
A Short History of B-Cell HLA EpitopesIlias Doxiadis, Henry Loeffler-Wirth, Nils Lachmann, et al.
Frontiers in Immunology|June 6, 2024
Homozygosity in any HLA locus is a risk factor for specific antibody production: the taboo concept 2.0Henry Loeffler-Wirth, Claudia Lehmann, Nils Lachmann, et al.
Pageof 9